| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.8M | +190.5% |
| Cost of Revenue | $33.8M | +330.1% |
| R&D Expense | $2.8M | +76.2% |
| SG&A Expense | $24.4M | +142.3% |
| Operating Income | -$59.1M | -6860.4% |
| Interest Expense | $4.3M | +92.2% |
| Pre-tax Income | -$72.1M | — |
| Income Tax | -$150K | -4480.8% |
| Net Income | -$72.0M |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.1M | — |
| Accounts Receivable | $451K | +369.8% |
| Current Assets | $32.0M | — |
| Total Assets | $53.6M | -8.2% |
| Current Liabilities | $43.0M | — |
| Long-term Debt | $51.9M | — |
| Total Liabilities | $61.5M | +1702.1% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$43.0M | -6998.1% |
| Investing Cash Flow | -$11.7M | -2463.3% |
| Financing Cash Flow | $75.9M | — |
| — |
| Stockholders' Equity |
| -$7.8M |
| -257.0% |